Prostate Cancer Trial, Recruiting NCT06659926 Sponsor: The Netherlands Cancer Institute Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT06659926
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with prostate cancer that has been confirmed by a tissue sample (biopsy).
  • Your cancer has been getting worse despite previous treatment, shown by rising PSA levels or new growth seen on scans.
  • A bone scan has shown cancer has spread to the bones, with at least two affected spots.
  • Your blood counts are at an acceptable level — specifically, your haemoglobin (red blood cell level) and platelet count meet the minimum required values (confirm exact values with trial site).
  • You are already receiving, or are able to receive, bone-protecting medication and hormone therapy to reduce testosterone, in line with current medical guidelines.

Who may not be able to join:

  • Your general health and ability to carry out daily activities is significantly limited (confirm with trial site what level of limitation would apply).
  • Your life expectancy is estimated to be less than 6 months.
  • Scans have shown that your cancer has spread to areas outside the bones, or to lymph nodes that are larger than a certain size.

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The Netherlands Cancer Institute
Registry
ClinicalTrials.gov
Start date
24 February 2025
Est. completion
1 July 2029

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Clinical progression free survival (cPFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov